Table 4 Association of VF genes and phylogroups between ESBLs and non-ESBL clinical isolates.
VF genes (Number, %) | ESBL (n = 95) | Non-ESBL (n = 49) | aP | Phylogroups (Number, %) | ESBL (n = 95) | Non-ESBL (n = 49) | aP |
|---|---|---|---|---|---|---|---|
traT (84, 58.3) | 64 | 20 | 0.002 | A (34, 23.6%) | 27 | 7 | 0.059 |
ompT (87, 60.4) | 50 | 37 | 0.008 | B1 (2, 1.4%) | 1 | 1 | 0.632 |
iutA (79, 54.9) | 48 | 31 | 0.147 | B2 (51, 35.4%) | 27 | 24 | 0.015 |
fimH (69, 47.9) | 45 | 24 | 0.855 | C (11, 7.6%) | 7 | 4 | 0.865 |
iha (56, 38.9) | 32 | 24 | 0.075 | D (16, 11.1%) | 11 | 5 | 0.804 |
hlyA (26, 18.1) | 25 | 1 | < 0.001 | E (2, 1.4%) | 1 | 1 | 0.632 |
papC (23, 16) | 12 | 11 | 0.129 | F (28, 19.4%) | 21 | 7 | 0.326 |
cvcC (3, 2.1) | 3 | 0 | 0.210 | Clade I (0, 0%) | 0 | 0 | 1.000 |
